Unique ID issued by UMIN | C000000406 |
---|---|
Receipt number | R000000494 |
Scientific Title | Clinical effects of azasetoron / dexamethasone combination-therapy on the prevention of nausea and vomiting caused by chemotherapy treatment for colon cancer patients - Comparative cross-over trial between azasetoron single-therapy and azasetoron/dexamethasone combination-therapy - |
Date of disclosure of the study information | 2006/04/17 |
Last modified on | 2006/04/14 17:46:16 |
Clinical effects of azasetoron / dexamethasone combination-therapy on the prevention of nausea and vomiting caused by chemotherapy treatment for colon cancer patients
- Comparative cross-over trial between azasetoron single-therapy and azasetoron/dexamethasone combination-therapy -
Comparative cross-over trial between azasetoron single-therapy and azasetoron/dexamethasone combination-therapy
Clinical effects of azasetoron / dexamethasone combination-therapy on the prevention of nausea and vomiting caused by chemotherapy treatment for colon cancer patients
- Comparative cross-over trial between azasetoron single-therapy and azasetoron/dexamethasone combination-therapy -
Comparative cross-over trial between azasetoron single-therapy and azasetoron/dexamethasone combination-therapy
Japan |
colon cancer
Gastroenterology | Hematology and clinical oncology | Gastrointestinal surgery |
Malignancy
NO
To compare antiemetic prophylactic effects and safety through the randomized cross-over trial between azasetoron single-therapy and azasetron/dexamethasone combination-therapy for colon cancer patients treated with chemotherapeutic agents such as Irinotecan, Oxaliplatin, Levofolinate and 5-FU
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
inhibition rate of vomiting events
vomiting frequency, score of nausea, patient's feelings (anti-emesis, appetite)
Interventional
Cross-over
Randomized
Individual
Single blind -participants are blinded
Active
Numbered container method
2
Treatment
Medicine |
drip-infusion of azasetoron (10mg/body) before the administration of anti-cancer agents (day1)
drip-infusion of azasetoron (10mg/body) and dexamethason (8mg/body) before the administration of anti-cancer agents (day1)
20 | years-old | <= |
80 | years-old | > |
Male and Female
Colon cancer patients to be administered with chemotherapeutic agents such as Irinotecan, Oxaliplatin, Levofolinate or 5-FU (underlying disease: colon cancer)
Patients who have the abilities to agree with this study by themselves, or whose acceptance to this study can be obtained from their proxies in writing
Patients to receive surgical treatment or irradiation treatment during the term of this study
Patients who develop complications of severe cardiovascular disease, hemodyscrasia, renal disease or hepatic disease.
Pregnant or lactating women
Patients with a history of hypersensitivity to any of the drugs used in this study.
100
1st name | |
Middle name | |
Last name | Yasushi Ichikawa |
Yokohama City University Graduate School of Medicine
Department of Gastroenterological Surgery
3-9 Fukuura, Kanazawa-Ku, Yokohama
1st name | |
Middle name | |
Last name |
Yokohama City University Graduate School of Medicine
Department of Gastroenterological Surgery
045-787-2650
Yokohama City University Graduate School of Medicine
Yokohama City University Graduate School of Medicine
Self funding
NO
2006 | Year | 04 | Month | 17 | Day |
Unpublished
Preinitiation
2006 | Year | 01 | Month | 31 | Day |
2006 | Year | 04 | Month | 01 | Day |
2008 | Year | 03 | Month | 01 | Day |
2006 | Year | 04 | Month | 14 | Day |
2006 | Year | 04 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000494
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |